Antiarrhythmic drug therapy in cardiomyopathies remains challenging because arrhythmic risk, drug efficacy, and pro-arrhythmic vulnerability vary substantially across phenotypes. This review summarizes contemporary guideline and consensus recommendations on antiarrhythmic drug use in hypertrophic, dilated, non-dilated...
Andrea Palermi, Massimo Di Marco, S. Saraullo et al.· Current Cardiology Reports· 0 citations
An integrated approach incorporating reproductive history, psychosocial conditions, socioeconomic circumstances, and environmental exposures into cardiovascular risk assessment may support more personalized prevention, reduce health inequalities, and inform clinical, community-based, and policy interventions.
Camilla Cocchi, Giandomenico Bisaccia, Maria Luana Rizzuto et al.· Current problems in cardiolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.